The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Iohexol-Global Market Insights and Sales Trends 2025
Synopsis
Iohexol (CAS 66108-95-0)
The global Iohexol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Iohexol in various end use industries. The expanding demands from the Contrast Agents, Diagnostic Agents and Others,, are propelling Iohexol market. 0.99, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 0.98 segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Iohexol market, driven by demand from China, the second largest economy with some signs of stabilising, the Iohexol market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Iohexol, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Iohexol market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Iohexol market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Iohexol sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Iohexol covered in this report include Zhejiang Hichi Pharmaceutical, LGC Group, Shanghai Shucan, Zhejiang Hisyn Pharmaceutical, Zhejiang Starry Pharmaceutical, Interpharma Praha, Beijing Beilu Pharmaceutical and GE Healthcare, etc.
The global Iohexol market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zhejiang Hichi Pharmaceutical
LGC Group
Shanghai Shucan
Zhejiang Hisyn Pharmaceutical
Zhejiang Starry Pharmaceutical
Interpharma Praha
Beijing Beilu Pharmaceutical
GE Healthcare
Global Iohexol market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Iohexol market, Segment by Type:
0.99
0.98
Others
Global Iohexol market, by Application
Contrast Agents
Diagnostic Agents
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Iohexol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Iohexol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Iohexol (CAS 66108-95-0)
The global Iohexol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Iohexol in various end use industries. The expanding demands from the Contrast Agents, Diagnostic Agents and Others,, are propelling Iohexol market. 0.99, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 0.98 segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Iohexol market, driven by demand from China, the second largest economy with some signs of stabilising, the Iohexol market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Iohexol, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Iohexol market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Iohexol market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Iohexol sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Iohexol covered in this report include Zhejiang Hichi Pharmaceutical, LGC Group, Shanghai Shucan, Zhejiang Hisyn Pharmaceutical, Zhejiang Starry Pharmaceutical, Interpharma Praha, Beijing Beilu Pharmaceutical and GE Healthcare, etc.
The global Iohexol market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zhejiang Hichi Pharmaceutical
LGC Group
Shanghai Shucan
Zhejiang Hisyn Pharmaceutical
Zhejiang Starry Pharmaceutical
Interpharma Praha
Beijing Beilu Pharmaceutical
GE Healthcare
Global Iohexol market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Iohexol market, Segment by Type:
0.99
0.98
Others
Global Iohexol market, by Application
Contrast Agents
Diagnostic Agents
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Iohexol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Iohexol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Iohexol Market Overview
1.1 Iohexol Product Overview
1.2 Iohexol Market Segment by Type
1.2.1 0.99
1.2.2 0.98
1.2.3 Others
1.3 Global Iohexol Market Size by Type
1.3.1 Global Iohexol Market Size Overview by Type (2018-2029)
1.3.2 Global Iohexol Historic Market Size Review by Type (2018-2023)
1.3.3 Global Iohexol Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Iohexol Sales Breakdown by Type (2018-2023)
1.4.2 Europe Iohexol Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Iohexol Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Iohexol Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Iohexol Sales Breakdown by Type (2018-2023)
2 Global Iohexol Market Competition by Company
2.1 Global Top Players by Iohexol Sales (2018-2023)
2.2 Global Top Players by Iohexol Revenue (2018-2023)
2.3 Global Top Players by Iohexol Price (2018-2023)
2.4 Global Top Manufacturers Iohexol Manufacturing Base Distribution, Sales Area, Product Type
2.5 Iohexol Market Competitive Situation and Trends
2.5.1 Iohexol Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Iohexol Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Iohexol as of 2022)
2.7 Date of Key Manufacturers Enter into Iohexol Market
2.8 Key Manufacturers Iohexol Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Iohexol Status and Outlook by Region
3.1 Global Iohexol Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Iohexol Historic Market Size by Region
3.2.1 Global Iohexol Sales in Volume by Region (2018-2023)
3.2.2 Global Iohexol Sales in Value by Region (2018-2023)
3.2.3 Global Iohexol Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Iohexol Forecasted Market Size by Region
3.3.1 Global Iohexol Sales in Volume by Region (2024-2029)
3.3.2 Global Iohexol Sales in Value by Region (2024-2029)
3.3.3 Global Iohexol Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Iohexol by Application
4.1 Iohexol Market Segment by Application
4.1.1 Contrast Agents
4.1.2 Diagnostic Agents
4.1.3 Others
4.2 Global Iohexol Market Size by Application
4.2.1 Global Iohexol Market Size Overview by Application (2018-2029)
4.2.2 Global Iohexol Historic Market Size Review by Application (2018-2023)
4.2.3 Global Iohexol Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Iohexol Sales Breakdown by Application (2018-2023)
4.3.2 Europe Iohexol Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Iohexol Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Iohexol Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Iohexol Sales Breakdown by Application (2018-2023)
5 North America Iohexol by Country
5.1 North America Iohexol Historic Market Size by Country
5.1.1 North America Iohexol Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Iohexol Sales in Volume by Country (2018-2023)
5.1.3 North America Iohexol Sales in Value by Country (2018-2023)
5.2 North America Iohexol Forecasted Market Size by Country
5.2.1 North America Iohexol Sales in Volume by Country (2024-2029)
5.2.2 North America Iohexol Sales in Value by Country (2024-2029)
6 Europe Iohexol by Country
6.1 Europe Iohexol Historic Market Size by Country
6.1.1 Europe Iohexol Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Iohexol Sales in Volume by Country (2018-2023)
6.1.3 Europe Iohexol Sales in Value by Country (2018-2023)
6.2 Europe Iohexol Forecasted Market Size by Country
6.2.1 Europe Iohexol Sales in Volume by Country (2024-2029)
6.2.2 Europe Iohexol Sales in Value by Country (2024-2029)
7 Asia-Pacific Iohexol by Region
7.1 Asia-Pacific Iohexol Historic Market Size by Region
7.1.1 Asia-Pacific Iohexol Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Iohexol Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Iohexol Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Iohexol Forecasted Market Size by Region
7.2.1 Asia-Pacific Iohexol Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Iohexol Sales in Value by Region (2024-2029)
8 Latin America Iohexol by Country
8.1 Latin America Iohexol Historic Market Size by Country
8.1.1 Latin America Iohexol Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Iohexol Sales in Volume by Country (2018-2023)
8.1.3 Latin America Iohexol Sales in Value by Country (2018-2023)
8.2 Latin America Iohexol Forecasted Market Size by Country
8.2.1 Latin America Iohexol Sales in Volume by Country (2024-2029)
8.2.2 Latin America Iohexol Sales in Value by Country (2024-2029)
9 Middle East and Africa Iohexol by Country
9.1 Middle East and Africa Iohexol Historic Market Size by Country
9.1.1 Middle East and Africa Iohexol Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Iohexol Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Iohexol Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Iohexol Forecasted Market Size by Country
9.2.1 Middle East and Africa Iohexol Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Iohexol Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Zhejiang Hichi Pharmaceutical
10.1.1 Zhejiang Hichi Pharmaceutical Company Information
10.1.2 Zhejiang Hichi Pharmaceutical Introduction and Business Overview
10.1.3 Zhejiang Hichi Pharmaceutical Iohexol Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Zhejiang Hichi Pharmaceutical Iohexol Products Offered
10.1.5 Zhejiang Hichi Pharmaceutical Recent Development
10.2 LGC Group
10.2.1 LGC Group Company Information
10.2.2 LGC Group Introduction and Business Overview
10.2.3 LGC Group Iohexol Sales, Revenue and Gross Margin (2018-2023)
10.2.4 LGC Group Iohexol Products Offered
10.2.5 LGC Group Recent Development
10.3 Shanghai Shucan
10.3.1 Shanghai Shucan Company Information
10.3.2 Shanghai Shucan Introduction and Business Overview
10.3.3 Shanghai Shucan Iohexol Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Shanghai Shucan Iohexol Products Offered
10.3.5 Shanghai Shucan Recent Development
10.4 Zhejiang Hisyn Pharmaceutical
10.4.1 Zhejiang Hisyn Pharmaceutical Company Information
10.4.2 Zhejiang Hisyn Pharmaceutical Introduction and Business Overview
10.4.3 Zhejiang Hisyn Pharmaceutical Iohexol Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Zhejiang Hisyn Pharmaceutical Iohexol Products Offered
10.4.5 Zhejiang Hisyn Pharmaceutical Recent Development
10.5 Zhejiang Starry Pharmaceutical
10.5.1 Zhejiang Starry Pharmaceutical Company Information
10.5.2 Zhejiang Starry Pharmaceutical Introduction and Business Overview
10.5.3 Zhejiang Starry Pharmaceutical Iohexol Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Zhejiang Starry Pharmaceutical Iohexol Products Offered
10.5.5 Zhejiang Starry Pharmaceutical Recent Development
10.6 Interpharma Praha
10.6.1 Interpharma Praha Company Information
10.6.2 Interpharma Praha Introduction and Business Overview
10.6.3 Interpharma Praha Iohexol Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Interpharma Praha Iohexol Products Offered
10.6.5 Interpharma Praha Recent Development
10.7 Beijing Beilu Pharmaceutical
10.7.1 Beijing Beilu Pharmaceutical Company Information
10.7.2 Beijing Beilu Pharmaceutical Introduction and Business Overview
10.7.3 Beijing Beilu Pharmaceutical Iohexol Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Beijing Beilu Pharmaceutical Iohexol Products Offered
10.7.5 Beijing Beilu Pharmaceutical Recent Development
10.8 GE Healthcare
10.8.1 GE Healthcare Company Information
10.8.2 GE Healthcare Introduction and Business Overview
10.8.3 GE Healthcare Iohexol Sales, Revenue and Gross Margin (2018-2023)
10.8.4 GE Healthcare Iohexol Products Offered
10.8.5 GE Healthcare Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Iohexol Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Iohexol Industrial Chain Analysis
11.4 Iohexol Market Dynamics
11.4.1 Iohexol Industry Trends
11.4.2 Iohexol Market Drivers
11.4.3 Iohexol Market Challenges
11.4.4 Iohexol Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Iohexol Distributors
12.3 Iohexol Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
